Daily pill shows promise for weight maintenance after stopping GLP-1 injections

For years, the promise of injectable weight-loss medications has been shadowed by a stubborn biological truth: when the injections stop, the body often reclaims what was lost. Researchers are now testing a daily oral pill designed to hold the metabolic ground gained during GLP-1 therapy, offering what could become a missing bridge between intensive treatment and lasting change. If it proves effective, this development may mark a quiet but profound shift in how medicine understands obesity — not as a condition to be periodically overcome, but one to be durably managed across time.